Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial (Q58863267)

From Wikidata

Jump to navigation Jump to search

scientific article published on 18 January 2012

Language	Label	Description	Also known as
English	Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial	scientific article published on 18 January 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261362%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261362%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

phase III clinical trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

0 references

head and neck carcinoma

1 reference

based on heuristic

inferred from title

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261362%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261362%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Jean Bourhis

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261362%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Christian Sire

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261362%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Pierre Graff

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261362%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Vincent Grégoire

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261362%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Philippe Maingon

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261362%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Gilles Calais

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261362%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Bernard Gery

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261362%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Laurent Martin

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261362%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Marc Alfonsi

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261362%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Patrick Desprez

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261362%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Thierry Pignon

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261362%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Etienne Bardet

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261362%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Michel Rives

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261362%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Lionel Geoffrois

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261362%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Nicolas Daly-Schveitzer

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261362%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Sok Sen

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261362%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Claude Tuchais

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261362%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Olivier Dupuis

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261362%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Stéphane Guerif

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261362%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Michel Lapeyre

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261362%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Véronique Favrel

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261362%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Antoine Lusinchi

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261362%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Stéphane Temam

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261362%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Antonella Pinna

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261362%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Pierre Blanchard

27

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261362%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Anne Aupérin

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261362%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

18 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261362%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261362%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261362%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261362%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

145-153

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261362%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970346-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970346-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970346-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970346-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970346-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970346-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiothera

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970346-1

7 January 2021

based on heuristic

inferred from DOI database lookup

French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970346-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970346-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970346-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970346-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970346-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase I trial combining oral cisplatin (CP Ethypharm) with radiotherapy in patients with locally advanced head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970346-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant chemotherapy prior to postoperative concurrent chemoradiotherapy for locoregionally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970346-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970346-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Human papillomavirus and survival of patients with oropharyngeal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970346-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970346-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970346-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970346-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970346-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970346-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Proton vs carbon ion beams in the definitive radiation treatment of cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970346-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(11)70346-1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261362%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22261362%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58863267&oldid=1759494258"